Begor Mark W 4
4 · EQUIFAX INC · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Equifax (EFX) CEO Mark Begor Exercises Options, Sells Shares
What Happened
- Mark W. Begor, CEO and Director of Equifax (EFX), exercised 37,791 stock options at $112.46/share (cost ≈ $4.25M) on 2026-02-10, and received a grant of 33,278 shares (RSUs). That same day he sold roughly 39,550 shares in multiple open-market transactions that generated about $8.0M in gross proceeds. One disposition of 1,759 shares was reported as tax withholding. The exercise also shows a corresponding conversion/disposition of the derivative position for 37,791 option shares (reported at $0 in the filing).
Key Details
- Transaction date: February 10, 2026; Form 4 filed February 12, 2026 (appears timely).
- Option exercise: 37,791 shares at $112.46 each (paid ≈ $4,249,976).
- Grant/award: 33,278 shares recorded as acquired (RSUs) at $0.00.
- Open-market sales: ~39,550 shares sold across multiple trades; weighted-average prices in the ~$192.6–$203.9 range; total proceeds ≈ $8.0M.
- Tax withholding: 1,759 shares withheld/used to satisfy tax obligations (coded F).
- Notable footnotes: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted 10/28/2025 (F1). Several sale lines list weighted-average prices with per-trade price ranges provided in the filing (F3–F13). Option vesting referenced (F14).
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
Context
- This appears to be a routine cashless exercise/sell pattern: the CEO exercised options, received shares (including RSUs), and sold many shares immediately in open-market trades (some to cover exercise/taxes). The 10b5-1 plan note indicates the sales were pre-arranged under an approved trading plan rather than opportunistic trades. These filings are factual disclosures and do not by themselves indicate insider sentiment.
Insider Transaction Report
Form 4
EQUIFAX INCEFX
Begor Mark W
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-02-10$112.46/sh+37,791$4,249,976→ 236,778 total - Award
Common Stock
[F2]2026-02-10+33,278→ 270,056 total - Sale
Common Stock
[F1][F3][F2]2026-02-10$197.79/sh−201$39,756→ 269,855 total - Sale
Common Stock
[F1][F4][F2]2026-02-10$203.76/sh−213$43,401→ 269,642 total - Sale
Common Stock
[F1][F5][F2]2026-02-10$192.89/sh−227$43,785→ 269,415 total - Sale
Common Stock
[F1][F6][F2]2026-02-10$194.22/sh−331$64,287→ 269,084 total - Sale
Common Stock
[F1][F7][F2]2026-02-10$195.40/sh−364$71,125→ 268,720 total - Sale
Common Stock
[F1][F8][F2]2026-02-10$196.43/sh−445$87,410→ 268,275 total - Sale
Common Stock
[F1][F9][F2]2026-02-10$199.00/sh−829$164,972→ 267,446 total - Tax Payment
Common Stock
[F2]2026-02-10$202.71/sh−1,759$356,567→ 265,687 total - Sale
Common Stock
[F1][F10][F2]2026-02-10$200.03/sh−1,772$354,452→ 263,915 total - Sale
Common Stock
[F1][F11][F2]2026-02-10$201.26/sh−4,057$816,522→ 259,858 total - Sale
Common Stock
[F1][F12][F2]2026-02-10$203.08/sh−11,000$2,233,871→ 248,858 total - Sale
Common Stock
[F1][F13][F2]2026-02-10$202.15/sh−18,352$3,709,939→ 230,506 total - Exercise/Conversion
Stock Option/Right to Buy
[F14]2026-02-10−37,791→ 113,374 totalExercise: $112.46Exp: 2028-05-04→ Common Stock (37,791 underlying)
Holdings
- 10,500(indirect: 2-yr 2025 GRAT)
Common Stock
- 21,284(indirect: 2-yr Dec 2025 GRAT)
Common Stock
- 22,045(indirect: 2-yr Jun 2025 GRAT)
Common Stock
- 12,333(indirect: 2-yr May 2025 GRAT)
Common Stock
- 16,287(indirect: 3-yr Jul 2024 GRAT)
Common Stock
Footnotes (14)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.
- [F10]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.67 to $200.481, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F11]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.672 to $201.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F12]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $202.665 to $203.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F13]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.67 to $202.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F14]The option vested in three equal annual increments beginning 5/4/2019.
- [F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.524 to $198.008, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $203.675 to $203.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $192.556 to $193.366, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F6]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $193.735 to $194.661, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F7]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $194.892 to $195.779, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F8]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.123 to $196.912, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F9]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.645 to $199.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
Signature
/s/Lisa Stockard as Attorney-in-Fact|2026-02-12